💊Pharmacology for Nurses Unit 19 – Heart Failure Drugs

What is Heart Failure?

• Chronic progressive condition where the heart muscle cannot pump enough blood to meet the body's needs for blood and oxygen
• Occurs when the heart cannot fill with enough blood or pump with enough force, or both
• Leads to symptoms such as shortness of breath, fatigue, and fluid retention (edema)
• Can be caused by conditions that damage the heart muscle, such as coronary artery disease, hypertension, and diabetes
• Classified into four stages (A, B, C, and D) based on the severity of symptoms and the degree of heart dysfunction
  • Stage A: High risk for developing heart failure but no structural heart disease or symptoms
  • Stage B: Structural heart disease but no signs or symptoms of heart failure
  • Stage C: Structural heart disease with prior or current symptoms of heart failure
  • Stage D: Refractory heart failure requiring specialized interventions
• Can affect the left side (left ventricle), right side (right ventricle), or both sides of the heart
• Increases the risk of complications such as arrhythmias, stroke, and kidney failure

Types of Heart Failure Drugs

• Diuretics (furosemide, bumetanide) help remove excess fluid from the body and reduce congestion
• ACE inhibitors (lisinopril, enalapril) dilate blood vessels and reduce the workload on the heart
• Angiotensin receptor blockers (losartan, valsartan) have similar effects to ACE inhibitors but work through a different mechanism
• Beta-blockers (carvedilol, metoprolol) slow the heart rate and reduce the workload on the heart
• Aldosterone antagonists (spironolactone, eplerenone) block the effects of aldosterone, a hormone that promotes fluid retention and increases the workload on the heart
• Digoxin increases the force of heart contractions and slows the heart rate
• Vasodilators (hydralazine, isosorbide dinitrate) dilate blood vessels and reduce the workload on the heart
• Inotropes (dobutamine, milrinone) increase the force of heart contractions and are used in acute decompensated heart failure

Mechanism of Action

• Diuretics act on the kidneys to increase urine production and remove excess fluid from the body
  • Loop diuretics (furosemide) inhibit the Na+/K+/2Cl- cotransporter in the thick ascending limb of the loop of Henle
  • Thiazide diuretics (hydrochlorothiazide) inhibit the Na+/Cl- cotransporter in the distal convoluted tubule
• ACE inhibitors block the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor and stimulator of aldosterone secretion
• Angiotensin receptor blockers directly block the binding of angiotensin II to its receptor (AT1)
• Beta-blockers block the effects of norepinephrine and epinephrine on beta-1 receptors in the heart, reducing heart rate and contractility
• Aldosterone antagonists compete with aldosterone for binding to mineralocorticoid receptors, reducing sodium and water retention
• Digoxin inhibits the Na+/K+ ATPase pump, increasing intracellular calcium and enhancing cardiac contractility
• Vasodilators relax smooth muscle in blood vessels, reducing peripheral resistance and afterload on the heart
• Inotropes increase intracellular calcium levels, enhancing cardiac contractility

Key Drug Classes and Examples

• Diuretics
  • Loop diuretics: furosemide, bumetanide, torsemide
  • Thiazide diuretics: hydrochlorothiazide, metolazone
  • Potassium-sparing diuretics: spironolactone, eplerenone, triamterene
• ACE inhibitors: lisinopril, enalapril, ramipril, captopril
• Angiotensin receptor blockers: losartan, valsartan, candesartan, irbesartan
• Beta-blockers: carvedilol, metoprolol succinate, bisoprolol
• Aldosterone antagonists: spironolactone, eplerenone
• Cardiac glycosides: digoxin
• Vasodilators: hydralazine, isosorbide dinitrate
• Inotropes: dobutamine, milrinone

Indications and Uses

• Diuretics are used to reduce fluid overload, relieve congestion, and improve symptoms of heart failure
• ACE inhibitors and angiotensin receptor blockers are used to reduce the workload on the heart, improve cardiac function, and slow the progression of heart failure
  • Also indicated for patients with left ventricular dysfunction after a myocardial infarction
• Beta-blockers are used to reduce the workload on the heart, improve symptoms, and prolong survival in patients with heart failure
  • Particularly beneficial in patients with reduced ejection fraction (HFrEF)
• Aldosterone antagonists are used in addition to other therapies to reduce morbidity and mortality in patients with severe heart failure (NYHA class III-IV) and left ventricular dysfunction
• Digoxin is used to improve symptoms and reduce hospitalizations in patients with heart failure and reduced ejection fraction
• Vasodilators are used in combination with other therapies to reduce afterload and improve symptoms in patients with heart failure
• Inotropes are used in acute decompensated heart failure to improve cardiac output and end-organ perfusion

Common Side Effects and Precautions

• Diuretics: electrolyte imbalances (hypokalemia, hyponatremia), dehydration, hypotension, renal dysfunction
  • Monitor electrolytes and renal function regularly
• ACE inhibitors and angiotensin receptor blockers: hypotension, hyperkalemia, renal dysfunction, angioedema
  • Contraindicated in pregnancy due to risk of fetal harm
• Beta-blockers: bradycardia, hypotension, fatigue, bronchospasm (in patients with asthma or COPD)
  • Initiate at low doses and titrate slowly to avoid worsening of heart failure symptoms
• Aldosterone antagonists: hyperkalemia, gynecomastia (spironolactone), renal dysfunction
  • Monitor potassium levels and renal function closely
• Digoxin: narrow therapeutic window, digoxin toxicity (nausea, vomiting, arrhythmias, visual disturbances)
  • Monitor digoxin levels and adjust dose accordingly
• Vasodilators: hypotension, headache, tachycardia
  • Use with caution in patients with low blood pressure or severe renal impairment
• Inotropes: arrhythmias, hypotension, increased myocardial oxygen demand
  • Reserve for short-term use in acute decompensated heart failure

Drug Interactions

• Diuretics: NSAIDs may reduce the efficacy of diuretics and increase the risk of renal dysfunction
• ACE inhibitors and angiotensin receptor blockers: concomitant use with potassium-sparing diuretics or potassium supplements may increase the risk of hyperkalemia
• Beta-blockers: may interact with calcium channel blockers (increased risk of bradycardia and heart block) and insulin or oral hypoglycemic agents (increased risk of hypoglycemia)
• Aldosterone antagonists: concomitant use with ACE inhibitors, angiotensin receptor blockers, or potassium supplements may increase the risk of hyperkalemia
• Digoxin: many drugs can increase or decrease digoxin levels, including amiodarone, verapamil, and quinidine
  • Monitor digoxin levels closely when initiating or adjusting concomitant medications
• Inotropes: may interact with beta-blockers (antagonistic effects) and antiarrhythmic agents (increased risk of arrhythmias)

Nursing Considerations

• Assess for signs and symptoms of heart failure (dyspnea, edema, fatigue) and monitor response to therapy
• Monitor vital signs, especially blood pressure and heart rate, and report significant changes
• Assess for side effects of medications and educate patients on how to recognize and report them
• Monitor electrolytes, renal function, and digoxin levels as appropriate for each medication
• Administer medications as prescribed and educate patients on the importance of adherence
• Encourage lifestyle modifications, such as salt restriction, fluid management, and regular exercise (as tolerated)
• Collaborate with the healthcare team to optimize treatment plans and ensure continuity of care
• Provide emotional support to patients and families coping with the challenges of heart failure

Patient Education Tips

• Explain the purpose and potential side effects of each medication in plain language
• Teach patients how to monitor their weight daily and report significant changes (>2-3 lbs in a day or >5 lbs in a week)
• Educate patients on the importance of adhering to their prescribed medication regimen and not stopping medications without consulting their healthcare provider
• Encourage patients to follow a low-sodium diet (<2-3 g/day) and to read food labels carefully
• Teach patients how to monitor and manage their fluid intake, if prescribed by their healthcare provider
• Emphasize the importance of regular follow-up appointments and reporting any worsening of symptoms
• Encourage patients to engage in regular physical activity, as tolerated and prescribed by their healthcare provider
• Provide resources for smoking cessation, stress management, and emotional support, as needed
• Educate patients on the signs and symptoms of medication side effects and when to seek medical attention